您好！歡迎訪問上海起發(fā)實驗試劑有限公司網(wǎng)站！
全國服務咨詢熱線:
15921799099
15921799099
Virogen 1003-P說明書
CATALOG #1003-P
摘要
用于八個ML ML
管的組織分解器含有物質(zhì)和珠子的管在水平和垂直方向上受到振蕩和撞擊，產(chǎn)生強烈的3D運動，導致組織或細胞的強大破壞。對于某些組織，破壞甚至比2ml管中的破壞更有效。它可以在冷藏室中使用或放在冰箱中，以保持樣品在低溫下消除噪音。由于快速中斷過程，樣品沒有加熱。
超過90％的研究和數(shù)千個臨床實驗室常規(guī)將組織均質(zhì)化用于他們的研究。該過程中的關鍵步驟是用玻璃珠破壞組織。Heartbreaker-2為用戶提供了優(yōu)于現(xiàn)有治療技術的*優(yōu)勢：
用戶的利益：
定制機器可用于：
貨號 | 品名 | 規(guī)格 | 價格 |
00211-V | HHV-4 recombinant p18 antigen Region: 1-119aa | 100ug/vial | 4845 |
00212-V | HHV-4 recombinant mosaic EBNA1 antigen. Region: 1-90/408-498aa | 100ug/vial | 4845 |
00213-V | HHV-4 recombinant EA antigen. Region: 306-390aa | 100ug/vial | 4845 |
00167-V | HDV Ag recombinant antigen | 100ug/vial | 4845 |
00214-V | Tick-born encephalitis virus gE recombinant antigen | 100ug/vial | 4845 |
00206-V | Toxoplasma gondii MIC 3 recombinant antigen | 100ug/vial | 4845 |
00207-V | Toxoplasma gondii P24 (GRA1) recombinant antigen | 100ug/vial | 4845 |
00208-V | Toxoplasma gondii P29 (GRA7) recombinant antigen | 100ug/vial | 4845 |
00209-V | Toxoplasma gondii P30 (SAG1) recombinant antigen | 100ug/vial | 4845 |
00111-V | HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa | 100ug/vial | 4845 |
00112-V | HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa | 100ug/vial | 4845 |
00113-V | HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa | 100ug/vial | 4845 |
00114-V | HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa | 100ug/vial | 4845 |
00168-V | HIV-1 p17/24/gp120-gp41 recombinant antigen. | 100ug/vial | 4845 |
00169-V | HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. | 100ug/vial | 4845 |
00170-V | HIV-1 gp41 recombinant antigen. | 100ug/vial | 4845 |
00171-V | HIV-1 gp41 Long recombinant antigen. | 100ug/vial | 4845 |
00172-V | HIV-1 p17-p24 recombinant antigen. | 100ug/vial | 4845 |
00173-V | HIV-2 gp32 recombinant antigen. . | 100ug/vial | 4845 |
00174-V | HIV-1 p24 recombinant antigen. | 100ug/vial | 4845 |
00175-V | HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide. | 100ug/vial | 4845 |
00176-V | HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41. | 100ug/vial | 4845 |
00177-V | HIV 1 p24 core recombinant antigen. | 100ug/vial | 4845 |
00178-V | HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. | 100ug/vial | 4845 |
00179-V | HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702. | 100ug/vial | 4845 |
00110-V | HIV-1 tat recombinant antigen full length 15 kDa | 100ug/vial | 4845 |
00180-V | HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. | 100ug/vial | 4845 |
00198-V | HIV-1 reverse transcriptase recombinant antigen. | 100ug/vial | 4845 |
00199-V | HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). | 100ug/vial | 4845 |
00115-V | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa | 100 ug/vial | 4845 |
00115-V-B | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. | 100 ug/vial | 4845 |
00115-V-F | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. | 100 ug/vial | 4845 |
00115-V-R | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. | 100 ug/vial | 4845 |
00116-V | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. | 100 ug/vial | 4845 |
00116-V-B | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. | 100 ug/vial | 4845 |
00116-V-F | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. | 100 ug/vial | 4845 |
00116-V-R | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. | 100 ug/vial | 4845 |
00117-V | HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa | 100 ug/vial | 4845 |
00150-V | HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a | 100 ug/vial | 4845 |
00151-V | HCV core 24 antigen. | 100 ug/vial | 4845 |
00152-V | HCV core recombinant antigen a.a.105-302 | 100 ug/vial | 4845 |
00153-V | HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a | 100 ug/vial | 4845 |
00154-V | HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 | 100 ug/vial | 4845 |
00155-V | HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. | 100 ug/vial | 4845 |
00156-V | HCV NS4 1916-1947aa recombinant antigen. | 100 ug/vial | 4845 |
00157-V | HCV NS5 2061-2302aa recombinant antigen. | 100 ug/vial | 4845 |
00158-V | HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. | 100 ug/vial | 4845 |
00120-V | HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa | 100 ug/vial | 4845 |
00121-V | HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa | 100 ug/vial | 4845 |
00122-V | HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant | 100 ug/vial | 4845 |
00123-V | HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity | 100 ug/vial | 4845 |
00124-V | HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant | 100 ug/vial | 4845 |
00131-V | HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. | 100 ug/vial | 4845 |
00132-V | HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. | 100 ug/vial | 4845 |
00133-V | HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. | 100 ug/vial | 4845 |
00141-V | T. Pallidum recombinant antigen p15 (full length) | 100 ug/vial | 4845 |
00142-V | T. Pallidum recombinant antigen p17 (full length) | 100 ug/vial | 4845 |
00143-V | T. Pallidum recombinant antigen p45 (full length) | 100 ug/vial | 4845 |
00144-V | T. Pallidum recombinant antigen TmpA (full length) | 100 ug/vial | 4845 |
00185-V | CMV Pp65 (UL83) recombinant antigen , full length | 100 ug/vial | 4845 |
00188-V | CMV Pp65 (UL83) recombinant antigen a.a. 297-510 | 100 ug/vial | 4845 |
00189-V | CMV Pp52 (UL44) recombinant antigen a.a. 271-428 | 100 ug/vial | 4845 |
00187-V | CMV gB-AD1 (UL55) recombinant antigen a.a. 549-645 | 100 ug/vial | 4845 |
00186-V | CMV Pp150 recombinant antigen a.a. 426-606 | 100 ug/vial | 4845 |
00159-V | HAV VP1-P2A recombinant antigen a.a. 722-830. | 100 ug/vial | 4845 |
00160-V | HAV VP4-VP2 recombinant antigen a.a. 55-164. | 100 ug/vial | 4845 |
00161-V | HAV P2C-P3A recombinant antigen a.a. 1492-1606. | 100 ug/vial | 4845 |
00162-V | HAV P3C recombinant antigen a.a. 1643-1743. | 100 ug/vial | 4845 |
00163-V | HAV VP3 recombinant antigen a.a. 304-415. | 100 ug/vial | 4845 |
00164-V | HAV VP1-P2A recombinant antigen a.a. 669-782. | 100 ug/vial | 4845 |
00165-V | HAV HAV P2C recombinant antigen a.a. 1121-1234. | 100 ug/vial | 4845 |
00166-V | HAV P2C-P3A recombinant antigen a.a. 1392-1521. | 100 ug/vial | 4845 |
00181-V | HSV-1 gD recombinant antigen a.a. 266-394. | 100 ug/vial | 4845 |
00182-V | HSV-2 gD recombinant antigen a.a. 266-394. | 100 ug/vial | 4845 |
00183-V | HSV-2 gD recombinant antigen a.a. 525-578. | 100 ug/vial | 4845 |
00184-V | HSV-1 gD recombinant antigen a.a. 84-175. | 100 ug/vial | 4845 |
1131-V | HSV-2 gB recombinant antigen | 100 ug/vial | 4845 |
00203-V | HLTV-I envelope recombinant antigen. C-terminus of gp-46 and most of p21. | 100 ug/vial | 4845 |
00204-V | HLTV-I p24 core recombinant antigen. | 100 ug/vial | 4845 |
00205-V | HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207. | 100 ug/vial | 4845 |
00700-V | HTLV-1 gp21 recombinant protein | 100 ug/vial | 4845 |
00701-V | HTLV-1 gp46 recombinant protein | 100 ug/vial | 4845 |
00215-V | Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239. | 100 ug/vial | 4845 |
00216-V | Rubella virus E2 recombinant antigen a.a. 31-105. | 100 ug/vial | 4845 |
00217-V | Rubella virus capsid (C) recombinant antigen a.a. 1-123. | 100 ug/vial | 4845 |
00191-V | SARS-Associated Coronavirus E recombinant antigen a.a. 1-76. | 100 ug/vial | 4845 |
00192-V | SARS-Associated Coronavirus Nucleocapsid recombinant antigen N a.a. 1-49. | 100 ug/vial | 4845 |
00193-V | SARS-Associated Coronavirus Nucleocapsid recombinant antigen C a.a. 340-390. | 100 ug/vial | 4845 |
00194-V | SARS-Associated Coronavirus M recombinant antigen a.a. 182-216. | 100 ug/vial | 4845 |
00195-V | SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. | 100 ug/vial | 4845 |
00196-V | SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. | 100 ug/vial | 4845 |
Virogen中國代理,Virogen上海代理，Virogen北京代理，Virogen廣東代理，Virogen江蘇代理Virogen湖北代理,Virogen天津代理,Virogen黑龍江代理,Virogen湖南代理Virogen內(nèi)蒙古代理,Virogen吉林代理,Virogen福建代理,Virogen江蘇代理,Virogen浙江代理,Virogen四川代理,Virogen代理，
上海起發(fā)實驗試劑有限公司是實驗試劑一站式采購服務商
1：強大的進口輻射能力，血清、抗體、耗材、大部分限制進口品等。
2：產(chǎn)品種類齊全，經(jīng)營超過700多品牌，基本涵蓋所有生物實驗試劑耗材。
3：提供加急服務，貨品一般1-2周到貨。
4：富有競爭良好的信譽，大部分客戶提供貨到付款服務。客戶包括清華、北大、交大、復旦、中山等100多所高校，ROCHE，阿斯利康、國藥、fisher等知藥企。
6：我們還是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech；sysy,TriLink BioTechnologies,Inc；worthington-biochem,zyagen等幾十家國外公司授權代理。
7：我們還是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知*批發(fā)，歡迎合作。
地址：上海浦東川沙鎮(zhèn)川沙路6619號上海起發(fā)實驗試劑有限公司
郵箱：xs1@78bio.com
傳真：021-50724961
電話
微信
當前位置：